Purpose of review Conventional wisdom maintains that multiple aspects of surgical technique and management may affect postoperative outcome, while anaesthetic technique has little long-term effect on patient outcomes. There is accumulating evidence that, on the contrary, anaesthetic management may in fact exert a number of longer-term effects in postoperative outcome. Here, we review the most topical aspects of anaesthetic management which may potentially influence later postoperative outcomes.
INTRODUCTION
Conventional wisdom maintains that anaesthetic technique has little influence on long-term patient outcomes, other than securing their safety, analgesia and comfort perioperatively.
This conviction is being challenged by gradually accumulating evidence that, on the contrary, anaesthetic management may indeed exert some hitherto unrecognized longer-term influences.
The list below summarizes the postoperative outcomes evaluated in this study:
(1) surgical site infections (SSIs); (2) cancer recurrence and metastases; (3) chronic postsurgical pain; (4) blood transfusion requirements; (5) postoperative myocardial infarction (MI) and stroke; (6) neurocognitive effects on the immature brain; and (7) cognitive dysfunction in the elderly.
WOUND HEALING AND SURGICAL SITE INFECTION
SSI is the infection in surgical wound which occurs postoperatively. It is a significant cause of major morbidity and increased economic cost. All surgical wounds become contaminated; whether it develops into a clinical infection depends on the balance between intrinsic patient, surgical and anaesthetic risk factors [1] . A major requirement for resisting SSI and successful wound healing is adequate delivery of oxygen to the tissues. Oxygen is required not only for tissue basal metabolism, but also for the formation of collagen (via proline hydroxlyase, an oxygen-dependent enzyme) [2] . Thus, a low tissue oxygen partial pressure can interfere with wound healing and result in poor collagen deposition leading to scar tissue of lower tensile strength and hence more prone to breakdown. Furthermore, oxygen is also a vital substrate for neutrophils and other phagocytic cells of the immune system, where it is metabolized by the enzyme neutrophil hydroxylase to superoxide and hydrogen peroxide free radicals, which kill bacteria [3] .
Many of the factors controlling tissue perfusion and hence oxygenation are influenced by anaesthetic management and are encapsulated by the Hagen-Poiseuille Law (Table 1 ) [1] .
In addition, suppression of thermoregulatory defence mechanisms during general anaesthesia is dose dependent and results in perioperative hypothermia [4] . Untreated inadvertent hypothermia causes autonomically mediated thermoregulatory vasoconstriction (increasing tissue vascular resistance) and reduces tissue oxygen partial pressure, thereby increasing the risk of SSI during the critical few hours following surgery when infection is initiated [5] .
The effect of active warming with a forced convective air warmer was evaluated in a prospective study which randomized 200 patients undergoing colorectal surgery to either routine intraoperative thermal care (core temperature allowed to decrease to approximately 34.58C) or active warming (core temperature maintained at 36.58C) [6] .
SSIs were found in 19% of patients assigned to hypothermia but in only 6% of patients assigned to normothermia (P ¼ 0.009). Time to discharge from hospital was prolonged in the hypothermia group 14.7 AE 6.5 vs. 12.1 AE 4.4 days in the normothermia (P ¼ 0.001). Therefore, maintaining normothermia intraoperatively reduces the incidence of SSI in patients undergoing colorectal resection and shortens their hospitalization.
Another prospective randomized trial of 421 patients investigating the effects of preoperative active warming prior to surgery found reduced infection rates 2-6 weeks after surgery, from 14% in the nonwarmed group to 5% in the actively warmed group [7] , with an absolute risk reduction of 7.9% [95% confidence interval (CI) 1.0-14.8] with systemic warming and 10.1% (3.6-16.6) with local warming.
Other perioperative factors which alter tissue oxygen partial pressure and hence impact on SSI are neuroendocrine stress response and acute postoperative pain. Both result in sympathetically mediated vasoconstriction, thus potentially reducing tissue oxygen partial pressure levels sufficiently to increase the risk of surgical wound infection [8] . Furthermore, the use of regional anaesthesia and analgesia may be superior to opioid-based analgesic regimens in increasing tissue oxygen tension through vasodilatation via sympathetic blockade [9, 10] .
As the final common pathway influencing SSI risk is tissue oxygen tension, administering supplemental perioperative oxygen reduces surgical site infections. Patients were randomly assigned to either 30 or 80% fraction of inspired oxygen (FiO 2 ) intraoperatively and for 6 h after surgery. Surgical site infection rates were reduced from 24% in patients administered FiO 2 ¼ 0.3 compared with 15% administered FiO 2 ¼ 0.8, P ¼ 0.04 [11] . The risk of SSI was 39% lower in the FiO 2 ¼ 0.8 group [relative
KEY POINTS
There is strong evidence that administration of supplemental oxygen and the avoidance of perioperative hypothermia, allogeneic blood transfusion, hyperglycaemia or large swings in blood glucose levels reduces postoperative infection rates.
There is some evidence that the use of regional anaesthesia techniques reduces chronic postsurgical pain and that avoidance of nitrous oxide reduces the long-term risk of myocardial infarction.
Current evidence is equivocal regarding the effects of anaesthesia techniques and cancer recurrence.
The instigation of perioperative beta-blockade in noncardiac surgery may not reduce perioperative adverse events or improve postoperative cardiovascular risk.
Further prospective, large-scale human trials with longterm follow-up are required to clarify the association between anaesthesia and cancer recurrence, neurotoxicity and postoperative cognitive dysfunction. [12] . They found a reduction in postoperative infection rates from 11% (95% CI 7.3-15.1%) to 5% (95% CI 2.4-8.0%; P ¼ 0.01). However, this benefit was not replicated in obese patients [13, 14] .
Increasing the tissue oxygen tension above a certain threshold may not reduce the risk of infection any further. A double-blind prospective trial of 143 women undergoing caesarean delivery under regional anaesthesia was randomly assigned to receive low-concentration or high-concentration inspired oxygen via nonrebreathing mask during the operation and for 2 h after the operation [15] . The study was halted after interim analysis of the first 25% of the planned sample size showed no benefit. Infection occurred in 25% (95% CI 15-35%) of 69 women assigned to high-concentration oxygen compared with 14% (95% CI 6-22%) of 74 women assigned to low-concentration inspired oxygen (RR 1.8, 95% CI 0.9-3.7; P ¼ 0.13).
Taken together, it seems that an anaesthetic management regimen that preserves physiological perfusion pressure, maintains adequate tissue oxygenation, avoids inadvertent perioperative hypothermia and maximizes analgesia, preferably with a regional technique, significantly reduces the risk of SSI.
CANCER RECURRENCE
Surgery is the primary and most effective treatment of many forms of cancer, but residual disease in the form of scattered micrometastases and tumour cells is inevitable. Whether minimal residual disease results in clinical metastases depends on the balance between host immune defence and tumour survival and growth. At least four perioperative factors shift the balance towards the progression of minimal residual disease:
(1) Surgery per se depresses cell-mediated immunity, increases concentrations of proangiogenic factors such as vascular endothelial growth factor (VEGF) and releases growth factors that promote growth of malignant tissue [16] . (2) Anaesthesia per se impairs numerous immune functions, including those of neutrophils, macrophages and natural killer cells [17] . (3) Postoperative pain, an inevitable consequence of cancer surgery, has itself been shown to facilitate metastatic spread of cancer in a live animal model [18] .
(4) Opioid analgesia, the mainstay of treatment of postoperative pain and cancer pain, inhibits cellular immune function in humans, increases angiogenesis and promotes breast tumour growth in rodents [19] .
However, regional anaesthesia and analgesia attenuates or prevents each of these adverse effects by largely preventing the neuroendocrine surgical stress response, eliminating or reducing the need for general anaesthesia and minimizing opioid requirement [20] . Animal studies indicate that regional anaesthesia and optimum postoperative analgesia reduces the metastatic burden in animals inoculated with breast adenocarcinoma cells following surgery [21] . There appears to be an inverse relationship between host natural killer cell activity and cancer recurrence, and host natural killer cell activity has been shown to be modulated by both perioperative stress and numerous anaesthetic and analgesic drugs [18, 22, 23 && ]. Nitrous oxide, by inhibiting methionine synthetase, reduces DNA and purine synthesis and suppresses neutrophil chemotaxis, potentially facilitating cancer spread. However, a FARCT (follow-up analysis of a previous randomized controlled trial) of 204 patients undergoing colon resection for bowel cancer, in which patients were randomly assigned to nitrous oxide or air (FiO 2 35% standardized between groups) with isoflurane and remifentanil based anaesthesia, found no statistically significant difference in cancer recurrence rates with a hazard ratio estimate of 1.10 (95% CI 0.66-1.83; P ¼ 0.72) [24] .
Although many opiates including morphine cause suppression of both cell-mediated and humoral immunity [19] , tramodol appears to have the opposite effect in humans and has been shown to enhance natural killer cell activity and reduce surgery-induced immune suppression and the associated higher metastatic burden in animal models and humans [25, 26] .
NSAIDS work by inhibiting the enzyme cyclooxygenase which is required for prostaglandin synthesis by tumour cells. In a live animal model, a single perioperative dose of indomethacin, etodolac or celecoxib blunted the surgical stressresponse induced suppression of natural killer cell cytotoxicity and reduced lung metastatic tumour retention (with additional benefit when used with a single dose of propranolol) [27, 28] . In a retrospective single-centre study of 327 consecutive women undergoing breast cancer surgery, the perioperative administration of ketorolac (but not diclofenac, due perhaps to a drug-specific, cyclo-oxygenase independent effect of ketorolac) was associated with a lower cancer recurrence rate (6 vs. 17%, hazard ratio 0.41, 95% CI 0-0.19; P ¼ 0.019) [29] . Local anaesthetic agents in animal and in-vitro models may also have tumour-suppressive effects. In-vitro lidocaine inhibits tumour cell proliferation and invasiveness [30] .
Given the potential immune-suppressive effects of the surgical stress response, general anaesthetics and opiates and the potential cancer-resistance effects of some NSAIDs and local anaesthetics, there appears to be a plausible rationale that an anaesthetic technique consisting of regional anaesthesia with propofol only general anaesthesia and nonopioid supplementary analgesia for cancer surgery might potentially reduce recurrence or metastasis. All human trials looking directly at cancer recurrence rates have been retrospective analyses. A retrospective study of 129 consecutive patients undergoing mastectomy and axillary clearance for breast cancer found that sevoflurane anaesthesia with paravertebral analgesia was associated with lower cancer recurrence rates (P ¼ 0.012) compared to opioid-based analgesia [31] . A review of 225 patients who underwent open radical prostatectomy for invasive prostate carcinoma found that those who received general anaesthesia plus epidural analgesia had an estimated 57% (95% CI 17-78%) lower risk of recurrence compared with general anaesthesia plus opioid analgesia (95% CI 0.22-0.83; P ¼ 0.012) [32] .
Other retrospective reviews however, have not found any such association [33, 34] (Table 2) .
A recently published long-term follow-up of the prospectively randomized controlled MASTER trial (n ¼ 446) in which patients were randomly assigned to receive general anaesthesia with or without epidural block failed to show an improved cancerfree survival in the epidural group [35 & ]. The median time to recurrence of cancer or death was 2.8 (95% CI 0.7-8.7) years in the control group and 2.6 (0.7-8.7) years in the epidural group (P ¼ 0.61). Recurrence-free survival was similar in both epidural and control groups (hazard ratio 0.95, 95% CI 0.76-1.17; P ¼ 0.61) prompting the authors to support expedition of the established randomized trials as soon as possible.
A prospective, international trial is ongoing, randomizing patients with primary breast cancer to an 'anticancer' anaesthetic technique (consisting of paravertebral regional anaesthesia and analgesia and propofol only general anaesthesia) vs. standard balanced general anaesthesia (based on volatile agent maintenance and opioid analgesia). Over 400 patients are enrolled already (NCT00418457).
In a smaller study (n ¼ 22), postoperative serum from women enrolled in this trial undergoing breast cancer surgery randomized to propofol/paravertebral anaesthesia-analgesia exhibited greater in-vitro inhibition of the proliferation of breast cancer cells vs. those randomized to sevoflurane general anaesthesia with opioid analgesia (P ¼ 0.01) [36] . This suggests that regional anaesthetic techniques, with superior analgesia, can alter the serum molecular milieu in ways less conducive to breast cancer cell function. In similar studies (n ¼ 40), the propofol-paravertebral anaesthetic technique was associated with much lower postoperative proangiogenic levels of VEGF-C (P ¼ 0.001) and higher levels of antiangiogenic transforming growth factor beta (P ¼ 0.005) [37] , and with increased expression of metastasis-promoting matrix metalloproteinases [38] .
Recently, the direct effect of morphine on breast cancer cell function was evaluated in vitro and found that it facilitates migration and proliferation in breast cancer cells, and that this may be mediated by the cancer-associated NET1 gene [39] . The outcome of the ongoing clinical trial must be awaited for definitive answers to the influence of anaesthetic techniques on recurrence or metastases.
PERIOPERATIVE GLYCAEMIC CONTROL AND LONG-TERM OUTCOMES
It is well established that long-term glycaemic control in diabetic patients results in lower morbidity and mortality rates. The question here is whether short-term tight perioperative glycaemic control can influence longer-term outcomes.
The concept of tight glycaemic control was developed in 2001 with a prospective trial of 1548 intensive care patients randomized to either blood glucose maintained between 4.4 and 6.1 mmol/l or allowed to reach 11.9 mmol/l respectively [40] . Results showed a reduction in ICU mortality from 8 to 4.6% in the tight glycaemic control group (P ¼ 0.04). Unfortunately, these results from a single centre have not been replicated by later, multicentre studies. Furthermore, concern over more frequent occurrences of hypoglycaemia [6.8 vs. 0.5%, odds ratio (OR) 14.7; 95% CI 9.0-25.9; P < 0.001] and increased mortality (27.5 vs. 24.9%, OR for death with intensive control 1.14, 95% CI 1.02-1.28; P ¼ 0.02) in those patients treated with intensive insulin therapy have overshadowed this regimen [41] .
But what of perioperative glucose control? In a prospective trial, 400 patients undergoing coronary artery bypass grafting (CABG) under cardiopulmonary bypass (CPB) were analysed comparing intraoperative tight glycaemic control (target blood glucose 4.4-5.6 mmol/l) with conventional treatment (no insulin unless blood glucose >11.1 mmol/l) [42] . This study included both diabetic and nondiabetic patients, as there is mounting evidence that stress-induced hyperglycaemia is also
Their results showed a statistically significant increase in the incidence of stroke in the tight glycaemic control group from 0.0049 to 0.04% (RR 8; P ¼ 0.02) and a trend towards increased mortality (P ¼ 0.061).
In a prospective study of 2467 diabetic patients undergoing open heart surgery, perioperative tight glycaemic control via a continuous insulin infusion vs. intermittent insulin injections with more lax blood glucose targets was associated with a 66% decrease in deep sternal wound infections (0.8 vs. 2%, P ¼ 0.01) [44] . But, it has been suggested that this benefit may be attributable to reduced variability in patient blood glucose levels rather than lower blood glucose levels per se.
Another prospective, single-centre trial looking at the rates of perioperative hypoglycaemic episodes randomized 483 normal patients undergoing elective or emergent intracranial procedures to intensive or conventional glycaemic management [45] . A greater fraction of patients in the intensive glucose treatment group had hypoglycaemic episodes (94 vs. 63% for conventional treatment; P ¼ 0.0001), but they also had a lower incidence of infections (26 vs. 39% for conventional therapy; P ¼ 0.002).
In a single-centre, prospective, observational study looking at tight perioperative glycaemic control in vascular surgery, 236 normal nondiabetic patients were randomly assigned to continuous insulin infusion (target glucose 5.6-8.3 mmol/l, aimed at reducing hypoglycaemic events during the study period) or to a standard intermittent insulin bolus (treat glucose >8.3 mmol/l) [46] . Treatments continued for 48 h with patients being followed until hospital discharge. Results showed a significant reduction in composite primary endpoints (all-cause death, MI and acute congestive heart failure) to 3.5% compared with 12.3% in the control group (RR 0.29; 95% CI 0.10-0.83; P ¼ 0.013). Multivariate analysis demonstrated that continuous insulin infusion was a negative independent predictor (OR 0.28; 95% CI 0.09-0.87; P ¼ 0.027) of adverse events.
A retrospective analysis of 4302 patients was conducted to compare the influence of intraoperative vs. postoperative glucose concentrations on risk of postoperative adverse outcomes after cardiac surgery [47 & ]. Patients (with and without diabetes) who had intraoperative hyperglycaemia of more than 11.1 mmol/l had a 90% increase in OR for mortality and approximately 50% increase in OR for overall morbidity. Patients with diabetes, despite being at increased risk for adverse outcome because of having diabetes, were at similar risk as patients without diabetes related to the degree of hyperglycaemia. Increased postoperative glycaemic variability was also associated with increased risk for adverse outcomes. Those patients who showed mild intraoperative hyperglycaemia (7.8-9.4 mmol/l) showed the lowest risk of mortality and overall morbidity. Postoperative hyperglycaemia is also an independent risk factor for surgical site infections [44, 48] .
A review in 2009 concluded that 'Although it is clear that hyperglycaemia is harmful, there is currently insufficient evidence to support the routine use of tight glycaemic control (target blood glucose 4.4-6.1 mmol/l) in the operating room or the ICU' [49] . The role of perioperative tight glycaemic control and its effects in modulating the long-term neurological outcome in patients who have experienced or are at risk for ischaemic brain injury remains to be elucidated. However, there emerging evidence that long-term infection risk and cardiovascular morbidity/mortality, may be optimized by:
(1) avoiding perioperative hyperglycaemia (while accepting higher blood glucose values than originally described by van den Berghe) in both diabetic and nondiabetic patients; and (2) administering insulin via a continuous intravenous infusion thereby avoiding large swings in blood glucose values.
BLOOD TRANSFUSION
Complications from blood transfusions are well documented [50] . Although many of these occur immediately or early in the perioperative period, others occur much later. The immunomodulatory effects of transfused allogeneic blood products have the potential to increase the risk of postoperative infections and cancer recurrence. A meta-analysis of prospective, randomized controlled trials totalling 13 152 patients comparing those who did and did not receive allogeneic blood (without distinguishing quantity) showed an OR in those transfused of 3.45 (range 1.43-15.15) for increased risk of all types of postoperative bacterial infection [51] . The effects of transfusion-related immunomodulation on cancer recurrence rates remains controversial [52] , but there is growing evidence that transfusion of allogeneic red cells, especially those stored for more than 9 days, promotes tumour growth [53] . A retrospective analysis of 6002 patients who received blood during CABG or heart valve surgery found that those who received blood stored for more than 14 days (n ¼ 2872, median 20 days) had higher rates of in-hospital mortality (2.8 vs. 1.7%, P ¼ 0.004), renal failure (2.7 vs. 1.6%, P ¼ 0.003), and sepsis (4.0 vs. 2.8%, P ¼ 0.01) compared to those who received blood which had been stored for less than 14 days (n ¼ 3130, median 11 days) [54] . At 1 year, mortality was significantly less in patients given blood less than 14 days old (7.4 vs. 11.0%, P < 0.001).
A long-term follow-up study (mean survival 49 months) of 67 patients who underwent pancreatoduodenectomy for carcinoma found that transfusion of 3 or more units of allogeneic red cells was associated with significantly poorer median (25 months) and cumulative 3-year and 5-year survivals (36.7 and 30.2%) than those of patients transfused with 2 units and/or nontransfused patients and was an independent poor prognostic factor (RR 2.082, 95% CI 1.48-4.315; P ¼ 0.036) [55] .
So how can anaesthetic and perioperative management reduce blood transfusion requirements?
One of the most significant predictors of requirement for allogeneic transfusion is a low preoperative haemoglobin level. Anaesthetists aware of preoperative anaemia may address this by preoperative treatment with (intravenous) iron and erythropoietin [56] . Mild inadvertent hypothermia (core body temperature <36.48C), with its deleterious effects on coagulation, significantly increases perioperative blood loss and increases allogeneic transfusion requirements [57] . Therefore, maintaining intraoperative normothermia using active warming methods not only reduces postoperative infection rates and reduces hospital length of stay, vide supra, but also reduces perioperative surgical bleeding and blood transfusion requirements and its associated longer-term complications.
Cell salvage is safe and effective at reducing allogeneic blood transfusion requirements and should be considered in all cases where significant blood loss is expected [58] . Not only does cell salvage reduce allogeneic transfusion requirements, it may also increase survival after oesophagectomy when compared with allogeneic blood transfusion [59] . The use of antifibrinolytic agents has been shown to reduce blood loss during cardiac, urologic and orthopaedic procedures [60] .
The effects of perioperative haemodilution in reducing transfusion requirements is less clear, as the dilutional effect occurs not only on red cells but also on coagulation factors and hence may be counterproductive, leading to reduced haemostasis. A recent prospective randomized study of 192 patients undergoing cardiac surgery under CPB found that restrictive intraoperative fluid administration [intravenous fluids preoperatively limited to 500 ml hydroxyethylstarch 6% (Voluven) accounted for 95% of fluid administered; 328 AE 157 ml] led to reduced red cell transfusion requirements compared with liberal fluid administration (at anaesthetists discretion: HES 6% accounted for 50% with the rest being crystalloid; 642 AE 222 ml). Those who were transfused required fewer red cell units intraoperatively: 31 units in 19 patients vs. 111 units in 62 patients; P < 0.001 [61 & ]. Propofol was associated with greater peripheral blood flow compared with sevoflurane as assessed by laser Doppler flowmeter during the prehypotensive intraoperative period and also the hypotensive intraoperative period in 28 patients undergoing spine surgery [62] . Despite this, blood loss and intraoperative bleeding were significantly reduced in the propofol group (106 AE 59 vs. 315 AE 99 ml; P ¼ 0.004). The authors suggest a selective vasodilatory effect of propofol (postcapillary, venous vasodilation), different from that of sevoflurane (precapillary, arteriolar vasodilation).
A well performed, prospective, randomized controlled trial looking at induced intraoperative hypotension (hypotension achieved by increasing the inspired isoflurane concentration) during orthognathic surgery found that MAP of 55-65 mmHg was associated with significantly less total blood loss (454 AE 211 ml) compared to MAP 75-85 mmHg (755 AE 334 ml; P < 0.001) [63] . There is little evidence that any one method of controlled intraoperative hypotension is superior in reducing intraoperative blood loss.
Strategies to minimize perioperative allogeneic blood transfusion are summarized in Table 3 .
PERIOPERATIVE b-BLOCKADE
Perioperative b-blockade, by attenuating the perioperative stress response, has been hypothesized to reduce the risk of cardiovascular events following noncardiac surgery. A recent meta-analysis of 33 trials including 12 306 patients looking at the use of b-blockers in noncardiac surgery extracted data for 30-day all-cause mortality, cardiovascular mortality, nonfatal MI, nonfatal stroke, heart failure and myocardial ischaemia [64] . The authors concluded that 'evidence does not support the use of b-blocker therapy for the prevention of perioperative clinical outcomes in patients having noncardiac surgery'. But, does the temporary perioperative instigation of b-blocker therapy in patients not already on a b-blocker alter the longerterm postoperative cardiovascular risk?
The largest, randomized, placebo-controlled, blinded, multicentre trial published to date looking at this question investigated 921 diabetic patients undergoing major noncardiac surgery [65] . Patients were randomized to 100 mg metoprolol extended release (n ¼ 462) or placebo (n ¼ 459) administered from the day before surgery to a maximum of eight perioperative days. The composite primary outcome measure was time to all-cause mortality, acute MI, unstable angina or congestive heart failure. The primary outcome occurred in 21% of patients in the metoprolol group and 20% of patients in the placebo group (hazard ratio 1.06, 0.80-1.41) during a median follow-up of 18 months. All-cause mortality was 16% (74/462) in the metoprolol group and 15.7% (72/459) in the placebo group (1.03, 0.74-1.42) .
The POISE trial [PeriOperative Ischaemic Evaluation trial: perioperative extended-release metoprolol succinate (n ¼ 4174) started 2-4 h before surgery and continued for 30 days vs. placebo (n ¼ 4177)] included a total of 8351 patients with, or at risk of, atherosclerotic disease who were undergoing noncardiac surgery [66] . The primary endpoint was a composite of cardiovascular death, nonfatal MI and nonfatal cardiac arrest within 30 days. Although fewer patients in the metoprolol group than in the placebo group had an MI (4.2 vs. 5.7%, P ¼ 0.0017), there were more deaths in the metoprolol group than in the placebo group (3.1 vs. 2.3%, P ¼ 0.0317). More patients in the metoprolol group than in the placebo group had a stroke (1.0 vs. 0.5%, P ¼ 0.0053). The report on the 1-year followup data from this study, which will represent by far the largest such long-term follow-up of the effects of perioperative b-blockade, is still awaited. If these data demonstrate a benefit at 1 year, clinicians and patients will have to balance this benefit against the 30 day excess of death and stroke with a b-blocker, as demonstrated in the original POISE study and subsequent meta-analysis.
THE USE OF NITROUS OXIDE
The continued use of nitrous oxide in modern anaesthetic practice, despite its long history, has been repeatedly called into question. There are plausible reasons to suspect increased long-term cardiovascular risk in patients receiving significant exposure to nitrous oxide. Nitrous oxide oxidizes the cobalt atom on vitamin B12, inactivating methionine synthase and causes a dose-dependent Table 3 . Strategies to minimize perioperative allogeneic blood transfusion Strategy for reducing perioperative blood loss and transfusion Putative mechanism increase in plasma homocysteine concentrations for days after surgery [67] . Acutely increased plasma homocysteine concentrations impair endothelial function, enhance platelet aggregation, induce oxidative stress and potentially destabilize coronary artery plaques [68] . Nitrous oxide -based anaesthesia has been reported to increase the incidence of myocardial ischaemia within 48 h and cardiovascular events within 30 h postoperatively [69] . The largest, prospective, randomized, multicentre trial (ENIGMA trial) looking at the effects of nitrous oxide-based anaesthesia and postoperative outcomes recruited 2050 patients having noncardiac surgery lasting more than 2 h [70] . Patients were randomized to nitrous oxide-based (70 : 30) or nitrous oxide-free anaesthesia (80 : 20, O 2 : N 2 ). Within 30 days of surgery, 16 patients had died (nine in the nitrous oxide group and three in the nitrous oxide-free group; P ¼ 0.10). Thirteen patients in nitrous oxide vs. seven patients in nitrous oxide-free group had a confirmed postoperative MI (P ¼ 0.20). There was no significant difference in the hospital length of stay.
A subsequent long-term follow-up study of the ENIGMA patients (median follow-up of 3.5 years) found that the administration of nitrous oxide was associated with an increased long-term risk of MI (37/ A potential limitation of the ENIGMA trial was that inspired O 2 concentrations were not the same in the two groups. Relatively, unselected patients were recruited with low 30-day and long-term event rates. The study therefore may have been underpowered to confidently confirm a 'true' increased risk of early postoperative MI in patients receiving nitrous oxide. Consequently, a larger multicentre randomized blinded trial of nitrous oxide-based vs. nitrous oxide-free anaesthesia in 7000 noncardiac surgery patients who have or are at risk of ischaemic heart disease has been commenced (ENIGMA-II trial) [72] . The results of this large international trial, due to be completed next year, will help clarify the association between nitrous oxide-based anaesthesia and long-term cardiovascular complications.
PERIOPERATIVE PAIN MANAGEMENT AND THE DEVELOPMENT OF CHRONIC PAIN
Chronic postsurgical pain (CPSP) is a pain syndrome whereby postoperative pain persists for more than 2 months after surgery with other causes for pain (e.g., pre-existing disease, recurrence of malignancy, chronic infection, etc.) excluded [73] . Known risk factors include patient factors (female sex, young age, obesity, preoperative anxiety, catastrophizing attitude and pre-existing pain) and surgical factors (invasive procedures: redo interventions, surgery in a previously injured area and particular surgical techniques) [74] . Acute postoperative pain intensity is also a strong predictor for the development of CPSP, though prospective studies on this point have produced mixed results. In a double-blinded, randomized controlled trial (n ¼ 82), maximal movement-evoked pain intensity over the first two postoperative days following total hip arthroplasty failed to predict the presence of CPSP 6 months later (P ¼ 0.38) [75] . Conversely, higher postdelivery pain following casesarean section was indeed found to be a predictor of chronic pain [76] . Some investigators believe that surgery, by cutting nerves or initiating prolonged inflammatory reactions, is the major determinant of CPSP [77] . Although no large prospective trial has confirmed that any specific anaesthetic intervention reduces the risk of CPSP, there is some evidence in smaller trials. In a single-centre, prospective, randomized controlled trial of 38 consecutive eligible patients undergoing elective thoracotomy under general anaesthesia, patients were randomized to either high-dose remifentanil with epidural analgesia started and at the end of surgery or low-dose remifentanil with epidural analgesia (0.5% ropivacaine) started at the beginning of anaesthesia [78] . The incidence of allodynia around the surgical incision and chronic pain (at 3, 6 and 9 months) was much higher in the group who received high-dose remifentanyl compared to those who received lowdose remifentanil with epidural analgesia during surgery (P < 0.001, and P ¼ 0.013, 0.008 and 0.009, respectively).
A recent, prospective, randomized controlled trial of perioperative analgesia in patients undergoing limb amputation surgery (n ¼ 65) found that optimized epidural analgesia or intravenous patient-controlled analgesia (PCA), starting 48 h preoperatively and continuing for 48 h postoperatively, decreased phantom limb pain at 6 months [79 & ]. The incidence of phantom limb pain at 6 months was one of 13 patients who had an epidural from 48 h preoperatively to 48 h postoperatively, four of 13 patients who had a preoperative PCA followed by epidural anaesthesia/analgesia extending to 48 h postoperatively, three of 13 patients who had a preoperative and postoperative PCA with a general anaesthetic vs. nine of 12 control patients who received a general anaesthesia with preoperative and postoperative conventional analgesia (P ¼ 0.001, 0.027 and 0.009, respectively).
A prospective, single-centre trial of patients undergoing breast surgery with axillary clearance randomized patients to a standard intraoperative and postoperative analgesic regimen (morphine sulphate, diclofenac, dextropropoxyphene hydrochloride plus acetaminophen prn, n ¼ 15) or a continuous paravertebral block for 48 h (n ¼ 14) with acetaminophen and parecoxib [80] . Acute postoperative pain scores were less in the paravertebral group at multiple time points extending from 30 min to day 4 postoperatively (P ¼ 0.005). Twelve (80%, a high incidence compared to other studies) patients in the standard analgesic group and no patients in the paravertebral group developed CPSP (P ¼ 0.009).
Although adequate treatment of acute postoperative pain is obligatory, there is no consistent prospective evidence that it prevents the development of CPSP. The literature currently available suggests that regional anaesthesia may help prevent the development of chronic postoperative pain. Large scale, prospective studies are required to clarify this important potential benefit of regional anaesthesia.
ANAESTHESIA AND THE DEVELOPING BRAIN
Several laboratory studies in neonatal animal models have demonstrated that administration of anaesthetic drugs is associated with an increase in apoptotic neuronal degeneration. This phenomenon has fuelled controversy about the implications for paediatric anaesthesia.
Apoptosis, or programmed cell death, is a vital part of neonatal central nervous system development. During normal foetal and neonatal development, neurons are produced in excess with subsequent neuronal degeneration occurring naturally in up to 70% of neurons and progenitor cells. However, the cellular mechanism for the activation of the apoptotic cascade and the cellular selectivity remains unresolved. It also remains unclear whether anaesthetics accelerate cell death in neurons destined to die because of natural apoptosis or if they trigger it in healthy neurons, which would have otherwise survived [81] .
Almost all animal models looking at the effects of anaesthetic agents on the developing brain are based on the 7-day-old mouse and rat. The equivalent time period in humans may be 17-20 weeks of gestation, potentially rendering the most commonly used animal models irrelevant for common paediatric anaesthesia practice [82] .
In contrast to the neurotoxicity model, there is some evidence that impaired neurogenesis and not cell death, particularly in the hippocampus, mediates anaesthesia-induced neurocognitive dysfunction [83] .
Direct evidence for the neurotoxic effect of anaesthetic agents on the developing brain comes entirely from in-vitro and animal models where dose-dependent neurodegeneration has been observed following exposure to thiopental, ketamine, propofol and isoflurane [84] but not nitrous oxide [85] .
It has long been known that surgery and anaesthesia in young children can lead to prolonged behavioural abnormalities [86] . But to what extent this is because of the neurotoxic effects of general anaesthetics as opposed to the psychological impact of the underlying illness, family reaction and the entire hospital experience as a whole remains uncertain.
There are reasons to suspect that anaesthetic neurotoxicity may not be to blame for these behavioural abnormalities. For example, the addition of a benzodiazepine before general anaesthesia has been shown not to exacerbate postoperative behavioural abnormalities, as expected for a cytotoxic cause, but rather significantly reduce abnormal behavioral symptoms [87] .
A population-based, retrospective, birth cohort study (n ¼ 5357), looking at the association between anaesthetic exposure before the age of 4 years and the development of language and numerical learning disabilities, found that compared with those not receiving anaesthesia (n ¼ 4764), a single general anaesthesia (n ¼ 449) was not associated with an increased risk of learning disabilities (hazard ratio ¼ 1.0; 95% CI 0.79-1.27) [88] . However, children receiving two anaesthetics (n ¼ 100) or three or more anaesthetics (n ¼ 44) were at increased risk for learning disabilities (hazard ratio ¼ 1.59; 95% CI 1.06-2.37 and hazard ratio ¼ 2.60; 95% CI 1.60-4.24, respectively). This study suggests a doseresponse relation (both in terms of number of anaesthetics received and the length of anaesthesia) between exposure to anaesthetic agents and the development of learning disabilities. It is also plausible that requiring multiple anaesthetics is a marker, rather than a cause, for conditions that increase the risk of learning disabilities.
A retrospective cohort study of siblings who had surgery/anaesthesia prior to 3 years of age (n ¼ 304) compared to an unexposed cohort (n ¼ 10 146) found that the risk of being subsequently diagnosed with a developmental and behavioural disorder was 60% greater than that of a similar group of siblings who did not undergo surgery [89] . The incidence of developmental and behavioural disorders was 128.2 diagnoses per 1000 person-years for the exposed cohort and 56.3 diagnoses per 1000 person-years for the unexposed cohort, P ¼ 0.04.
In contrast, a large Danish cohort study comparing the academic performance of all children who had undergone inguinal hernia repair in infancy (n ¼ 2689) to a randomly selected, age-matched 5% population sample (n ¼ 14 575) found no evidence that a single, general anaesthesia exposure in infancy reduced academic performance at age 15 or 16 after adjusting for known confounding factors [90 & ].
Given the importance of potential longer-term neurocognitive effects of anaesthetic agents on the developing human brain, large-scale, prospective, randomized controlled trials with long-term followup are required. To this end, a large multisite randomized controlled trial -Pediatric Anaesthesia & Neurodevelopment Assessment (PANDA) project -is in progress (www.kidspandastudy.org/). The PANDA study is a sibling matched cohort study that will enrol a total of 1000 children or 500 sibling pairs. The period of anaesthesia exposure will be before 36 months of age, with exposure limited to a single episode of general anaesthesia for inguinal hernia repair in ASA I and ASA II patients.
ANAESTHESIA AND POSTOPERATIVE COGNITIVE DYSFUNCTION
Postoperative cognitive dysfunction (POCD) is a poorly defined condition with numerous studies using different definitions and neuropsychological tests to detect potentially altered short or longerterm memory, motor control or information processing following anaesthesia. There is evidence that altered intraoperative physiology may influence POCD and longer-term outcomes: for example, a significant relationship between minimum intraoperative blood pressure in hypertensive patients undergoing spinal surgery and decline in cognitive function 1 day and 1 month after surgery has been observed [91] . POCD has an incidence of up to 80% following CPB and has been attributed, at least in part, to surgery-related trauma, microembolization, temperature changes and altered cerebral oxygenation/perfusion. We are focussing here on noncardiac surgical patients and the possible lasting effects of anaesthetic agents on the brain.
There is in-vitro and animal model evidence that neurotoxic effects of anaesthetics are not confined to the developing brain. Isoflurane has been shown to activate the membrane-bound IP 3 receptor producing excessive calcium release and triggering apoptosis in cells [92] .
In-vitro experiments suggest that some anaesthetics act in the processing of amyloid b-peptide providing a possible link between the effects of anaesthetics and postoperative cognitive sequelae. Clinical concentrations of isoflurane cause altered processing of amyloid precursor protein and increase amyloid b-peptide production in both human neuroglioma and mice brain cell lines [93] . There is also enhancement of Ab oligomerization that is thought to be responsible for synaptic dysfunction and neurodegeneration [94] .
Volatile anaesthetics, ketamine and barbiturates are potent inhibitors of acetylcholine receptorsthe very receptors that anticholinesterase drugs, used for the treatment of dementia, seek to enhance.
A meta-analysis of 21 studies on POCD and postoperative delirium (POD) found no effect of anaesthesia type on the OR of developing POD (0.88, 95% CI 0.51-1.51) [95] . In a small subgroup analysis of a prospective, randomized controlled trial [General Anaesthesia vs. Local Anaesthesia (GALA) study], 40 patients undergoing carotid endarterectomy (CEA) were randomized to receive either local anaesthesia (n ¼ 17) or general anaesthesia (n ¼ 23) [96] . Despite carotid clamping times being longer in the local anaesthesia group [mean 24 min (SD 10) vs. 15 min (SD 8), P ¼ 0.003] and less patients in the local anaesthesia group receiving a shunt [5 (9%) vs. 9 (39%), P ¼ 0.001], information processing, during psychometric testing, was found to be significantly slowed in the general anaesthesia group at 5 and 29 h but not at 77 h postoperatively, as compared to their preoperative baseline tests. There was no significant difference between the preoperative and postoperative results in the local anaesthesia group at any of the time points. This is the first prospective, randomized, albeit small, clinical study to show a beneficial effect of local anaesthesia on early postoperative cognitive function in CEA patients.
An observational study of 701 patients enrolled in two multicentre studies of POCD found that POCD at 3 months, but not at 1 week, was associated with increased mortality [hazard ratio, 1.63 (95% CI, 1.11-2.38); P ¼ 0.01, adjusted for sex, age and cancer] [97] . POCD is associated with poorer outcomes in terms of earlier retirement, increased dependency on social support and 70% 5-year mortality rate compared to 35% in those without POCD.
In an effort to discover a dose-response relationship between anaesthesia and POCD, a prospective observational study of 70 patients over 60 years of age undergoing elective noncardiac surgery measured depth of anaesthesia using a cerebral state monitor and compared the measured cerebral state index (CSI) to the performance of the patients on neuropsychological testing 1 week after surgery [98] .
The mean CSI was 40 and 43 in patients with (n ¼ 9) and without (n ¼ 56) POCD, P ¼ 0.41. The cumulated time of both deep anaesthesia (CSI <40) and light anaesthesia (CSI >60) did not differ significantly, and no significant correlation was found between the mean CSI and risk of POCD.
Persistent cognitive decline may be attributable to underlying undiagnosed neurological disease or other comorbidities rather than to surgery or to anaesthesia per se. There are other perioperative influences to which elderly people are more susceptible such as altered environment and sleep disturbance. Further large-scale prospective studies are required to investigate the possible prolonged effects of even short-acting anaesthetics on the elderly brain.
CONCLUSION
There is accumulating evidence that anaesthetic management may indeed exert a number of influences on longer-term postoperative outcomes. 
